Back to News
Market Impact: 0.2
IMU Biosciences And UK Biobank Partner To Build Large-Scale Human Immune Dataset
Source: Nasdaq
Healthcare & BiotechArtificial IntelligenceTechnology & Innovation
IMU Biosciences announced a collaboration with UK Biobank to generate high-resolution immune-profiling data from an initial cohort of 80,000 blood samples. The announcement provides no financial terms or reported results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- BlackRock, GIC among investors chasing Indian telecom major Jio's IPO as anchor bids top $26 billion
- Nscale, Anthropic Eye $45 Billion Cloud Deal as AI Trade Rebounds
- Asia stocks slump as AI jitters hammer Korean chipmakers ahead of tech earnings
- Elice shares plunge 28% on debut as investor doubts over AI trade deepen
- Gartner analyst behind tech rout: AI returns are not yet large enough to justify neocloud build-out
- Tech stocks had a nice oversold bounce on Monday. Earnings this week will determine if it's for real